LDK378

Alectinib · Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for LDK378, covering 2014-08-11 to 2020-12-24. Get the full timeline:

Most recent: Clinical Trial Update: LDK378 in Patients With ALK Positive NSCLC Previously Treated With Alectinib. [Phase 2]